HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples.
about
Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease researchGenomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancersGraft-versus-host disease biomarkers: omics and personalized medicineWorld Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: IV. Tissue collection, processing, and storage in endometriosis researchLC-MS-based metabolomicsAn update on microRNAs as colorectal cancer biomarkers: where are we and what's next?Assessing bias in experiment design for large scale mass spectrometry-based quantitative proteomicsProteomics in uveal melanoma research: opportunities and challenges in biomarker discoveryMass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimensThe effect of pre-analytical variability on the measurement of MRM-MS-based mid- to high-abundance plasma protein biomarkers and a panel of cytokinesDegradation and Stabilization of Peptide Hormones in Human Blood Specimensα-Mangostin Extraction from the Native Mangosteen (Garcinia mangostana L.) and the Binding Mechanisms of α-Mangostin to HSA or TRFEvaluating the effects of preanalytical variables on the stability of the human plasma proteomeReview: the use of proteomics as a research methodology for studying cancer-related fatigue: a review.Classification-based comparison of pre-processing methods for interpretation of mass spectrometry generated clinical datasets.Thrombin induces broad spectrum proteolysis in human serum samples.Comparing the MicroRNA spectrum between serum and plasmaA method for improving SELDI-TOF mass spectrometry data quality.Peptidomic analysis of breast cancer reveals a putative surrogate marker for estrogen receptor-negative carcinomas.Human body fluid proteome analysis.Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias.Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients.Validation of previously identified serum biomarkers for breast cancer with SELDI-TOF MS: a case control studyAdvanced proteomic technologies for cancer biomarker discovery.Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.Variation in protein levels obtained from human blood cells and biofluids for platelet, peripheral blood mononuclear cell, plasma, urine and saliva proteomicsInfluence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS).Approaching clinical proteomics: current state and future fields of application in fluid proteomics.A proteomic approach for plasma biomarker discovery with iTRAQ labelling and OFFGEL fractionation.Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.Feature detection techniques for preprocessing proteomic data.Cardiovascular proteomics: implications for clinical applicationsHigh-throughput and targeted in-depth mass spectrometry-based approaches for biofluid profiling and biomarker discovery.Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology.ProteoMiner™ and SELDI-TOF-MS: a robust and highly reproducible combination for biomarker discovery from whole blood serum.Data management and data integration in the HUPO plasma proteome project.Impact of the storage temperature on human plasma proteomic analysis: implications for the use of human plasma collections in research.Elevated plasma albumin and apolipoprotein A-I oxidation under suboptimal specimen storage conditions.Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.High abundance proteins depletion vs low abundance proteins enrichment: comparison of methods to reduce the plasma proteome complexity.
P2860
Q24289435-1F86B468-F773-4242-80A0-1128B5FAE01BQ26751068-28690663-49DA-430F-B08A-F95EBC7B9780Q26824540-3C230F42-FEF5-445E-9C9D-97033B2E4A49Q26827259-027B2CA7-1F06-407B-9311-2617D2111FFEQ27015012-4CE5642B-EF1A-4BAF-B166-A566799A4564Q27024427-B68D7077-37D6-4AFF-B1D2-64EDF5F6F949Q28235692-5F8A75A1-A1DB-45F8-B719-BDF44DA03F50Q28297411-F3736B0A-D7BD-422E-942A-ED14E6E78564Q28307595-ACDA524C-A3F1-4DC7-B743-89004F879DAFQ28484137-FEF04146-B3B2-4C61-BF6A-C38322E07025Q28546842-13C68700-12DF-4B9E-87F1-52A4730466BFQ28553838-97159FA3-A405-4ADD-9F68-2A85E16955D2Q30372676-DEE70C44-5623-4E87-B356-F64E00A19250Q30385237-80876350-9D84-4981-BA19-69B079B175FAQ30487959-143026A1-A3D0-4661-A61F-6A554845FB80Q30855514-14324290-39EE-4740-9018-D15F20FB3957Q31080442-EC5C95BB-3CA6-4CAE-BD75-96E288B19487Q31125985-AA19DE44-7DF0-4438-84FC-9BF56A5C1EADQ33234191-E67CD705-31A9-4D0E-A5CB-735792419CB9Q33262623-00FCE8E1-2A85-4CED-AB28-1AF9FBC4BFF4Q33304961-BAA48B77-9437-40F1-8B1E-5D16D1281F28Q33395871-24CB4D7E-01DA-4F94-B2A1-A44F8FD7DDFEQ33400847-1DB6B4EC-058E-437F-9F60-60C60F3E5093Q33433660-4A928AEA-3528-483D-99DA-15BB5FDB7220Q33436829-89DF4D61-FBBB-4E4F-AD51-55C1537ADE74Q33437720-1B651BA2-1FE3-4438-871D-5DD891FD226EQ33439145-389B6FB5-F0E1-4DFD-8AE1-338CAFF75B14Q33467523-6FA7AB1B-85EA-4AD4-A295-F9CA70E164A4Q33514848-E07D26C1-9984-404E-A00B-FA0A4D93CB57Q33520447-72D52C1B-DF95-4C16-9F56-00B2013F7715Q33577873-7BB14211-D372-4FB4-897A-7BAFD5BFED7AQ33579184-EC6BABCC-ECA2-4CCB-BCB4-6683E3A9F5E3Q33579375-A4DD3F62-A069-4A0F-84A7-3705EF346E24Q33605010-B5341B5A-31D0-4276-9DF4-FFD30B984C84Q33642003-EF78B7E2-666B-4A4B-A393-B732AAE99762Q33743194-0265373E-5301-4CFB-B022-46B4A73777C5Q33776978-C65D7BBC-97BF-4166-A5CA-7F43CE9829D7Q33850682-66898BAE-C1E0-4A31-A64B-C394C2634F9BQ33891197-0A460CFC-6485-434D-B25B-BA1BFFCBDA6EQ33900798-AA3F1DB4-7B1A-4766-BE01-437DD7E304B9
P2860
HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
HUPO Plasma Proteome Project s ...... s for plasma proteome samples.
@ast
HUPO Plasma Proteome Project s ...... s for plasma proteome samples.
@en
type
label
HUPO Plasma Proteome Project s ...... s for plasma proteome samples.
@ast
HUPO Plasma Proteome Project s ...... s for plasma proteome samples.
@en
prefLabel
HUPO Plasma Proteome Project s ...... s for plasma proteome samples.
@ast
HUPO Plasma Proteome Project s ...... s for plasma proteome samples.
@en
P2093
P356
P1433
P1476
HUPO Plasma Proteome Project s ...... s for plasma proteome samples.
@en
P2093
Alex J Rai
Brian B Haab
Bruce C Haywood
Craig A Gelfand
Daniel W Chan
David J Warunek
David W Speicher
Frank Vitzthum
Gerard Siest
Graham B I Scott
P304
P356
10.1002/PMIC.200401245
P577
2005-08-01T00:00:00Z